These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
552 related articles for article (PubMed ID: 19074844)
1. Combination of antiangiogenesis with chemotherapy for more effective cancer treatment. Ma J; Waxman DJ Mol Cancer Ther; 2008 Dec; 7(12):3670-84. PubMed ID: 19074844 [TBL] [Abstract][Full Text] [Related]
2. Antiangiogenesis and vascular disrupting agents in cancer: circumventing resistance and augmenting their therapeutic utility. Close A Future Med Chem; 2016; 8(4):443-62. PubMed ID: 26933926 [TBL] [Abstract][Full Text] [Related]
3. Antiangiogenic strategies and agents in clinical trials. Rosen L Oncologist; 2000; 5 Suppl 1():20-7. PubMed ID: 10804087 [TBL] [Abstract][Full Text] [Related]
4. Antiangiogenic therapy for cancer: an update. Al-Husein B; Abdalla M; Trepte M; Deremer DL; Somanath PR Pharmacotherapy; 2012 Dec; 32(12):1095-111. PubMed ID: 23208836 [TBL] [Abstract][Full Text] [Related]
5. Antiangiogenic therapy for cancer: current and emerging concepts. Jain RK Oncology (Williston Park); 2005 Apr; 19(4 Suppl 3):7-16. PubMed ID: 15934498 [TBL] [Abstract][Full Text] [Related]
6. Assessing the in vivo efficacy of biologic antiangiogenic therapies. Wilson PM; LaBonte MJ; Lenz HJ Cancer Chemother Pharmacol; 2013 Jan; 71(1):1-12. PubMed ID: 23053262 [TBL] [Abstract][Full Text] [Related]
7. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Jain RK Science; 2005 Jan; 307(5706):58-62. PubMed ID: 15637262 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms and future directions for angiogenesis-based cancer therapies. Scappaticci FA J Clin Oncol; 2002 Sep; 20(18):3906-27. PubMed ID: 12228212 [TBL] [Abstract][Full Text] [Related]
10. Newly discovered angiogenesis inhibitors and their mechanisms of action. Miao ZH; Feng JM; Ding J Acta Pharmacol Sin; 2012 Sep; 33(9):1103-11. PubMed ID: 22922347 [TBL] [Abstract][Full Text] [Related]
11. Angiogenic inhibitors: a new therapeutic strategy in oncology. Gasparini G; Longo R; Toi M; Ferrara N Nat Clin Pract Oncol; 2005 Nov; 2(11):562-77. PubMed ID: 16270097 [TBL] [Abstract][Full Text] [Related]
12. Tumor angiogenesis and accessibility: role of vascular endothelial growth factor. Jain RK Semin Oncol; 2002 Dec; 29(6 Suppl 16):3-9. PubMed ID: 12516032 [TBL] [Abstract][Full Text] [Related]
13. Silencing or fueling metastasis with VEGF inhibitors: antiangiogenesis revisited. Loges S; Mazzone M; Hohensinner P; Carmeliet P Cancer Cell; 2009 Mar; 15(3):167-70. PubMed ID: 19249675 [TBL] [Abstract][Full Text] [Related]
14. Combination therapy in cancer: effects of angiogenesis inhibitors on drug pharmacokinetics and pharmacodynamics. Fuso Nerini I; Cesca M; Bizzaro F; Giavazzi R Chin J Cancer; 2016 Jun; 35(1):61. PubMed ID: 27357621 [TBL] [Abstract][Full Text] [Related]
15. The possible role of chemotherapy in antiangiogenic drug resistance. Bocci G; Loupakis F Med Hypotheses; 2012 May; 78(5):646-8. PubMed ID: 22365648 [TBL] [Abstract][Full Text] [Related]